Modified ex-PRESS technique versus Ahmed glaucoma valve as primary glaucoma surgery for hereditary transthyretin amyloidosis glaucoma

2024-9-10

No body fits in the test tube – the case of transthyretin

2024-9-8

International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction

2024-9-8

T2-relaxometry in a large cohort of hereditary transthyretin amyloidosis with polyneuropathy

2024-9-2

A report from the European Proteomics Amyloid Network (EPAN)

2024-8-22

Brain MRI in patients with V30M hereditary transthyretin amyloidosis

2024-8-17

Anti-PEG antibodies associated with reduced therapeutic effect of patisiran in patients with hereditary transthyretin amyloidosis

2024-8-10

ELISA-4-amyloid: diagnostic accuracy of an ELISA panel for typing the four main types of systemic amyloidosis in subcutaneous abdominal fat tissue samples

2024-8-6

Successes in translation

2024-8-5

Clinical and molecular insights into A97S variants in hereditary transthyretin amyloid polyneuropathy in South China

2024-7-31

Altered connectivity of central autonomic network: effects of dysautonomia in hereditary transthyretin amyloidosis with polyneuropathy

2024-7-24

Response to therapy with tafamidis 61 mg in patients with cardiac transthyretin amyloidosis: real-world experience since approval

2024-7-17

Glaucoma is not seen at a higher prevalence in age-related transthyretin amyloidosis after race stratification

2024-7-14

Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis

2024-7-11

Internalisation of immunoglobulin light chains by cardiomyocytes in AL amyloidosis: what can biopsies tell us?

2024-7-7

Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy

2024-7-2

Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis

2024-7-1

Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis

2024-5-27

Genetic counselling for at-risk family members with hereditary transthyretin amyloidosis: data from a single-centre study

2024-5-25

1. Daily life in patients with hereditary transthyretin amyloidosis: a qualitative study

2024-5-23

Gastrointestinal Amyloid Screening Study (GASS): is screening for amyloid in the gastrointestinal tract useful?

2024-5-21

Absence of an increased wall thickness does not rule out cardiac amyloidosis

2024-5-20

Patient-reported satisfaction with telemedicine in light chain (AL) amyloidosis care

2024-5-20

Double pathogenic variant in an ATTRv patient with mixed phenotype

2024-5-16

Heterogeneity in families with ATTRV30M amyloidosis: a historical and longitudinal Portuguese case study impact for genetic counselling

2024-4-8

Changes in the amyloid editorial board members and in editor positions

2024-4-2

Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis

2024-3-13

Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I <i>TTR</i> carriers in the general population

2024-3-6

Possible transmission of leukocyte chemotactic factor 2 amyloidosis after interpopulational liver transplantation

2024-3-5

Gait abnormalities in older adults with transthyretin cardiac amyloidosis

2024-3-3

Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice

2024-2-13

Mass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosis

2024-2-11

Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma

2024-1-11

Symptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosis

2023-12-21

Dual AApoAIV amyloidosis and ATTR amyloidosis arising in the same patient: a report of three cases

2023-12-15

Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis

2023-12-11

Longitudinal evolution of ventricular function and cardiac magnetic resonance imaging tissue characteristics in tafamidis-treated transthyretin amyloid cardiomyopathy

2023-12-9

Longitudinal PET/CT imaging with iodine ( ¹²⁴ I) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosis

2023-11-22

Identification of calcitonin receptor-stimulating peptide 1-derived amyloid in a feline C-cell carcinoma

2023-11-19

AA amyloidosis in a father and daughter as complication of <i>PSTPIP1</i> -associated myeloid-related proteinemia inflammatory (PAMI) syndrome

2023-10-23

Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study

2023-10-19

The way to a man’s heart: prostate samples for the early detection of transthyretin cardiomyopathy

2023-10-11

Inappropriate use of technetium-99m pyrophosphate scanning for the evaluation of transthyretin amyloidosis

2023-10-6

Heterogeneous worldwide access and pricing of Tafamidis

2023-10-3

Intra-familial variability of oculoleptomeningeal amyloidosis due to the ATTR I107M (c.381T &gt; G) mutation: diagnostic challenges of a rare phenotype

2023-9-27

Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study

2023-9-5

Reduction in ^99m Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathy

2023-8-20

Correction

2023-8-10

Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis

2023-8-2

Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis

2023-7-26